Asia Pacific Medical Collagen Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Bovine, Porcine, and Others), Product (Gelatine, Hydrolysed Collagen, Native Collagen, and Others), and Application (Wound Care, Bone Grafts, Tissue Scaffolds, Cartilage Repair, Haemostats, Diagnostics, Vascular Grafts, and Others)
Market Introduction
Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry.
Get more information on this report :
Market Overview and Dynamics
The Asia Pacific medical collagen market is expected to reach US$ 188.51 million by 2028 from US$ 118.73 million in 2021; it is estimated to register a CAGR of 6.8% from 2021 to 2028. The growth of the Asia Pacific medical collagen market is attributable to rising applications of collagen in the medical industry, surging disposable income, and growing middle-class population worldwide. However, medical collagen product recalls are hindering the growth of the market.
A medical product with collagen as a part is being studied to treat several conditions. Owing to its clinical and consumer acceptance, it is widely used as medical material. Collagen- based medical products such as bioprosthetic heart valves, arterial replacements, sutures used in surgical procedures, and wound dressings have been widely adopted. Thus, several research studies are being conducted to develop new collagen-based medical products. For instance, in 2020, MPM Medical initiated its CoMatryx Surgical Bovine Collagen Study. CoMatryx surgical collagen powder is a soft tissue repair product made of 100% Type-I Bovine collagen. Furthermore, research is being conducted to discover new sources of collagen for medical biomaterials. For instance, the study ‘Tilapia (Oreochromis aureus) Collagen for Medical Biomaterials’ was published in 2018. The researchers studied the potentials of tilapia skin as an alternative source of collagen for its application in medical biomaterial. Thus, the increasing research activities for collagen-based medical products are likely to drive the growth of the market during the forecast period. Also, the surge in disposable income, introduction of advanced technologies, and better aftercare have uplifted the number of cosmetic procedures being performed. Multinational corporations in the skin aesthetic industry have been prominently targeting India's huge population. As per the World Economic Forum, the number of households in India with disposable incomes of over US$ 10,000 increased 20-folds, from 2.5 million in 1990 to ~50 million in 2015. Thus, the growth in disposable income has enabled them to afford high-cost healthcare procedures such as cosmetic, orthopedic, and dental procedures thereby propelling the market growth.
Countries in Asia Pacific are facing challenges due to the increasing number of COVID-19 positive patients. The current scenario of COVID-19 pandemic has driven the governments to predominantly concentrate on containing the spread to COVID-19, due to which the focus on cosmetic treatments has temporarily drifted. The dermatology clinics, hospitals, and surgical centers are open for only emergency services. Also, medical tourism has declined in response to the pandemic in countries such as South Korea and Japan, thereby having a negative impact on the cosmetic industry and consequently affected the performance of the medical collagen market in Asia Pacific.
Key Market Segments
The Asia Pacific medical collagen market, by source, is segmented into bovine, porcine, and others. The bovine segment held the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period.
The Asia Pacific medical collagen market, by product, is segmented into gelatine, hydrolyzed collagen, native collagen, and others. The gelatine segment held the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period.
Based on application, the Asia Pacific medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and others. The wound care segment held the largest share of the market in 2020. However, the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Asia Pacific medical collagen market are the World Economic Forum, Australian Institute of Health and Welfare (AIHW) and Organization for Economic Co-operation and Development (OECD).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Asia Pacific medical collagen market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Asia Pacific medical collagen market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific medical collagen market.
ASIA PACIFIC MEDICAL COLLAGEN MARKET SEGMENTATION
By Source
- Bovine
- Porcine
- Others
By Product
- Gelatine
- Hydrolysed Collagen
- Native Collagen
- Others
By Application
- Wound Care
- Bone Grafts
- Tissue Scaffolds
- Cartilage Repair
- Haemostats
- Diagnostics
- Vascular Grafts
- Other
By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Company Profiles
- ENCOLL Corp
- GELITA AG
- Collagen Matrix, Inc.
- Integra Life Sciences Corporation
- Croda International plc
Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Medical Collagen Market – By Source
1.3.2 Asia Pacific Medical Collagen Market – By Product
1.3.3 Asia Pacific Medical Collagen Market – By Application
1.3.4 Asia Pacific Medical Collagen Market– By Country
2. Medical Collagen Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Medical Collagen Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Medical Collagen Market– Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Applications of Collagen in Medical Industry
5.1.2 Growing FDA Approvals and Product Launches
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Surging Disposable Income and Expanding Middle-Class Population Worldwide
5.4 Future Trends
5.4.1 Increasing Research Activities for Collagen Based Medical Products
5.5 Impact Analysis
6. Medical Collagen Market– Asia Pacific Analysis
6.1 Asia Pacific Medical Collagen Market Revenue Forecast and Analysis
7. Medical Collagen Market Analysis – By Source
7.1 Overview
7.2 Medical Collagen Market Revenue Share, by Source (2020 and 2028)
7.3 Bovine
7.3.1 Overview
7.3.2 Bovine: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Porcine
7.4.1 Overview
7.4.2 Porcine: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
8. Medical Collagen Market Analysis – By Product
8.1 Overview
8.2 Medical Collagen Market Revenue Share, by Product (2020 and 2028)
8.3 Gelatine
8.3.1 Overview
8.3.2 Gelatine: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Hydrolysed Collagen
8.4.1 Overview
8.4.2 Hydrolysed Collagen: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Native Collagen
8.5.1 Overview
8.5.2 Native Collagen: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
8.6 Other
8.6.1 Overview
8.6.2 Other: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
9. Medical Collagen Market– By Application
9.1 Overview
9.2 Medical collagen Market, by Application, 2020 and 2028 (%)
9.3 Haemostats
9.3.1 Overview
9.3.2 Haemostats: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Vascular Grafts
9.4.1 Overview
9.4.2 Vascular Grafts: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Tissue Scaffolds
9.5.1 Overview
9.5.2 Tissue Scaffolds: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Cartilage Repair
9.6.1 Overview
9.6.2 Cartilage Repair: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Wound Care
9.7.1 Overview
9.7.2 Wound Care: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
9.8 Bone Grafts
9.8.1 Overview
9.8.2 Bone Grafts: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
9.9 Diagnostics
9.9.1 Overview
9.9.2 Diagnostics: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
9.10 Others
9.10.1 Overview
9.10.2 Others: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
10. Medical Collagen Market Analysis and Forecasts to 2028 Asia Pacific Analysis
10.1 Asia Pacific: Medical Collagen Market
10.1.1 Overview
10.1.3 Asia Pacific: Medical Collagen Market, by Country, 2020 & 2028 (%)
10.1.4 China: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 China: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 China: Medical Collagen Market, by Source, 2019–2028 (USD Million)
10.1.4.3 China: Medical Collagen Market, By Product, 2019–2028 (USD Million)
10.1.4.4 China: Medical Collagen Market, by Application, 2019–2028 (USD Million)
10.1.5 Japan: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 Japan: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.2 Japan: Medical Collagen Market, by Source, 2019–2028 (USD Million)
10.1.5.3 Japan: Medical Collagen Market, By Product, 2019–2028 (USD Million)
10.1.5.4 Japan: Medical Collagen Market, By Application, 2019–2028 (USD Million)
10.1.6 India: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1 India: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 India: Medical Collagen Market, by Source, 2019–2028 (USD Million)
10.1.6.3 India: Medical Collagen Market, By Product, 2019–2028 (USD Million)
10.1.6.4 India: Medical Collagen Market, By Application, 2019–2028 (USD Million)
10.1.7 South Korea: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 South Korea: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 South Korea: Medical Collagen Market, by Source, 2019–2028 (USD Million)
10.1.7.3 South Korea: Medical Collagen Market, By Product, 2019–2028 (USD Million)
10.1.7.4 South Korea: Medical Collagen Market, By Application, 2019–2028 (USD Million)
10.1.8 Australia: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Australia: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Australia: Medical Collagen Market, by Source, 2019–2028 (USD Million)
10.1.8.3 Australia: Medical Collagen Market, By Product, 2019–2028 (USD Million)
10.1.8.4 Australia: Medical Collagen Market, By Application, 2019–2028 (USD Million)
10.1.9 Rest of Asia-Pacific: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.1 Rest of Asia-Pacific: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.2 Rest of Asia-Pacific: Medical Collagen Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.9.3 Rest of Asia-Pacific: Medical Collagen Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.9.4 Rest of Asia-Pacific: Medical Collagen Market, by Application – Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Medical Collagen Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 ENCOLL Corp.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GELITA AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Collagen Matrix, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Integra Life Sciences Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Croda International plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China Medical Collagen Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 2. China Medical Collagen Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 3. China Medical Collagen Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Japan Medical Collagen Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 5. Japan Medical Collagen Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 6. Japan Medical Collagen Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 7. India Medical Collagen Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 8. India Medical Collagen Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 9. India Medical Collagen Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 10. South Korea Medical Collagen Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 11. South Korea Medical Collagen Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 12. South Korea Medical Collagen Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Australia Medical Collagen Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 14. Australia Medical Collagen Market, By Product – Revenue and Forecast to 2028 (USD Million)
Table 15. Australia Medical Collagen Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Asia-Pacific: Medical Collagen Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Asia-Pacific: Medical Collagen Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia-Pacific: Medical Collagen Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms, Medical Collagen Market
LIST OF FIGURES
Figure 1. Medical Collagen Market Segmentation
Figure 2. Medical Collagen Segmentation, By Country
Figure 3. Asia Pacific Medical Collagen Market Overview
Figure 4. Bovine Held Largest Share of Source Segment in Medical Collagen Market
Figure 5. Asia Pacific Medical Collagen Market– Leading Country Markets (US$ Million)
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Medical Collagen Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Medical Collagen Market– Revenue Forecast and Analysis – 2020- 2028
Figure 9. Medical Collagen Market Revenue Share, by Source (2020 and 2028)
Figure 10. Bovine: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Porcine: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Others: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Medical Collagen Market Revenue Share, by Product (2020 and 2028)
Figure 14. Gelatine: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Hydrolysed Collagen: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Native Collagen: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Other: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Medical collagen Market, by Application, 2020 and 2028 (%)
Figure 19. Haemostats: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Vascular Grafts: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Tissue Scaffolds: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Cartilage Repair: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Wound Care: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Bone Grafts: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Diagnostics: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Medical Collagen Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Asia Pacific: Medical Collagen Market, by Key Country – Revenue (2020) (USD Million)
Figure 28. China: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Japan: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. India: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. South Korea: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Australia: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Rest of Asia-Pacific: Medical Collagen Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Impact of COVID-19 Pandemic on Medical Collagen Market in Asia Pacific Countries
- ENCOLL Corp
- GELITA AG
- Collagen Matrix, Inc.
- Integra Life Sciences Corporation
- Croda International plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific medical collagen market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific nitinol medical collagen market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.